DUBLIN, Sept. 25, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/mjgg25/investigation) has announced the addition of the "Investigation Report on China's Loversol Market, 2010-2019" report to their offering.
Contrast medium is commonly used to enhance the visibility of blood vessels and body cavity. And its application area has expanded from X- ray/CT imaging to ultrasound scattering and magnetic resonance imaging. In recent years, contrast agent market in China has maintained a growth of about 20%. Ioersol, in particular, has reported a growth of 60%. Currently, ioersol is used in many hospitals due to its cheap price and good quality.
Ioversol enjoys a vast demand with sales value of ioversol rising from less than CNY 30 million in 2005 to over CNY 200 million in 2014 and CAGR during this period reaching 27%. Mallinckrodt Medical Inc.(Canada), Mallinckrodt Medical Inc.(USA) and Jiangsu Hengrui Medicine Co., Ltd mainly occupy the market, among which Jiangsu Hengrui Medicine Co., Ltd had the largest market share of over 80% for sales value in 2014.
Key Topics Covered:
1 Related Concepts of Ioversol
2 Market Profile of Ioversol in China
3 Survey on Ioversol Sales in China, 2010-2014
4 Survey on Market Share of Major Ioversol Manufacturers in China, 2010-2014
5 Survey on Dosage Forms of Ioversol in China, 2010-2014
6 Reference Price of Ioversol in Chinese Hospitals in 2014
7 Major Manufacturers of Ioversol in Chinese Market, 2010-2014
8 Market Outlook of Ioversol in China, 2015-2019
- Jiangsu Hengrui Medicine Co., Ltd
- Mallinckrodt Medical Inc.
For more information visit http://www.researchandmarkets.com/research/mjgg25/investigation
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets